Methotrexate vs Tofacitinib
Methotrexate vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Methotrexate and Tofacitinib.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5; Tofacitinib β C16H20N6O.
Molecular Weight: Methotrexate β 454.4400 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Methotrexate β Small molecule; Tofacitinib β Small molecule.